Non-invasive Aesthetic Treatment Market Forecast, Trend, Analysis and Competition Tracking – Global Market Insights 2022 to 2030

The global Non-invasive Aesthetic Treatment market size is expected to be worth around US$ 150.0 billion by 2030, according to a new report by Vision Research Reports.

The global Non-invasive Aesthetic Treatment market size was valued at US$ 49.0 billion in 2020 and is anticipated to grow at a CAGR of 15.7% during forecast period 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39012

Report Coverage

Report Scope Details
Market Size US$ 150.0 billion by 2030
Growth Rate CAGR of 15.7% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Procedure, End use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Allergan; Hologic (cynosure); Johnson & Johnson; Galderma; Lumenis; Solta Medical; Syneron Candela; Alma Laser

Growth Factors

Growing focus on physical appearance among adults has led to an increased demand for non-invasive aesthetic treatment in recent years. Another key revenue-generating population to watch out for are the ones aged 50+ years and above. Women in this age group are opting for fillers and injectablesincluding the popular, Botox. According to the American Society for Aesthetic Plastic Surgery (ASAPS), in 2019, around 3.8 million minimally invasive cosmetic surgeries were carried out in the US within the age group of 55 and above. The COVID-19 pandemic has significantly affected the non-invasive aesthetic treatment market. The cosmetics industry relies on close physical contact with their clients, leaving it negatively affected. Practitioners have also raised concerns over the downturn in inpatient interest owing to a sharp cut in income level. The market for non-invasive aesthetic treatment is expected to witness a phase of short-term negative growth.

By Procedure Analysis

The injectables segment dominated the market for non-invasive aesthetic treatment and accounted for the largest revenue share of 64.0% in 2021. Injectables can be easily used by surgeons and provide faster treatment with quick results and less downtime as compared to others.

Laser hair removal is fast gaining popularity as it is cost-effective and saves time compared to waxing, shaving, or using hair removal cream. According to the International Society of Aesthetic Plastic Surgery (ISAPS), hair removal was among the top 5 nonsurgical procedures carried out at a global level in 2020.

By End-use Analysis

The medspa segment dominated the market for non-invasive aesthetic treatment accounted for the largest revenue share of 33.9% in 2021. The end-user segment is divided into Hospital/Surgery Center, Medspa, Traditional Spa, HCP owned clinics.

Medspa is a facility where cosmetic services are provided under the supervision of a licensed physician. All noninvasive treatments are performed in these facilities, which include facial injections, non-invasive body contouring, skin rejuvenation, and laser treatments by experienced professionals.

Medspas are increasingly adopting novel treatment systems to cater to a wider esthetic need of patients, therefore the segment is witnessing growth. The employees in Medspas need to have a license in esthetics as well as a medical education.

By Regional Analysis

North America dominated the market for non-invasive aesthetic treatment and held the largest revenue share of 38.4% in 2021 owing to increasing demand for cosmetic procedures by both adults and the geriatric population.

In the Asia Pacific, the market for non-invasive aesthetic treatment is expected to witness the highest CAGR of 16.6% during the forecast period. The region is backed by countries such as China, India, and Thailand.

Key Players

  • Hologic, Inc.
  • Allergan, Inc.
  • Galderma S.A
  • Alma Lasers
  • Syneron Candela
  • Johnson & Johnson
  • MerzPharma
  • Lumenis
  • Solta
  • Cutera Inc.

Market Segmentation

  • Procedure Type
    • Injectables
      • Botulinum Toxin
      • Calcium Hydroxylapatite
      • Hyaluronic Acid
      • Polymer Filler
      • Collagen
    • Skin Rejuvenation
      • Chemical Peel
      • Laser Skin Resurfacing
      • Photorejuvenation
    • Others
      • Hair Removal
      • Nonsurgical Fat Reduction
      • Sclerotherapy
      • Cellulite Treatment
  • End-use
    • Hospital/Surgery Center
    • Medspa
    • Traditional Spa
    • HCP owned clinic
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Thailand
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39012

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Non-invasive Aesthetic Treatment Market, By Procedure Type

7.1.  Non-invasive Aesthetic Treatment Market, by Procedure Type, 2021-2030

7.1.1.    Injectables

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Skin Rejuvenation

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Non-invasive Aesthetic Treatment Market, By End-use

8.1.  Non-invasive Aesthetic Treatment Market, by End-use, 2021-2030

8.1.1.    Hospital/Surgery Center

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Medspa

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Traditional Spa

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    HCP owned clinic

8.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Non-invasive Aesthetic Treatment Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

9.1.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.1.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.1.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

9.2.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.2.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.2.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.2.5.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.2.6.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

9.3.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.3.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.3.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.3.5.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.3.6.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

9.4.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.4.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.4.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.4.5.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.4.6.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

9.5.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.5.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.5.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

Chapter 10.  Company Profiles

10.1.              Hologic, Inc.

10.1.1.  Company Overview

10.1.2.  Procedure Type Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Allergan, Inc.

10.2.1.  Company Overview

10.2.2.  Procedure Type Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Galderma S.A

10.3.1.  Company Overview

10.3.2.  Procedure Type Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Alma Lasers

10.4.1.  Company Overview

10.4.2.  Procedure Type Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Syneron Candela

10.5.1.  Company Overview

10.5.2.  Procedure Type Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Johnson & Johnson

10.6.1.  Company Overview

10.6.2.  Procedure Type Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              MerzPharma

10.7.1.  Company Overview

10.7.2.  Procedure Type Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Lumenis

10.8.1.  Company Overview

10.8.2.  Procedure Type Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Solta

10.9.1.  Company Overview

10.9.2.  Procedure Type Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Cutera Inc.

10.10.1.               Company Overview

10.10.2.               Procedure Type Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39012

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com